BCDA

BioCardia, Inc.

Healthcare · Biotechnology

$256.05 sample

+0.88 (+0.34%) 1D

Market cap

$1.43T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-23

Alerts

8

Price$256.05 +3.35% 3M daily closessample

259.52243.15

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider sell: General Counsel
Sep 23SEC10-Q filed
Sep 14INSInsider sell: General Counsel
Sep 09SECForm 144 filed
Sep 02INSInsider buy: Director
Aug 28INSInsider sell: EVP, Operations
Aug 21INSInsider sell: General Counsel
Aug 14INSInsider sell: General Counsel

Sign up to see the real BCDA record →

Company facts

SEC EDGAR registration

Name: BioCardia, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +47sample, -100 to +100
Reporting currency: USD

Who is positioning in BCDA

sample

Insiders: 11 insider transactions over 90 days, net selling, $757.5M
Congress: No member trades over 90 days
Institutions · 13F: 35 funds hold $12.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$41.9B +14.3% y/y

Q4 2024Q3 2026

Inventory$26.0B +10.7% y/y

Q4 2024Q3 2026

Accounts receivable$19.0B +14.7% y/y

Q4 2024Q3 2026

Total debt$49.7B +14.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $644.0B -2.9% 3M
Sample peer B: $1.09T +4.2% 3M
Sample peer C: $935.5B +2.1% 3M
Sample peer D: $1.03T +2.0% 3M
Sample peer E: $1.36T -10.5% 3M